Farabi Pharmaceutical (XTEH:DFRB1) Total Operating Expense: IRR0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Farabi Pharmaceutical Total Operating Expense?

Farabi Pharmaceutical XTEH:DFRB1 Total Operating Expense is IRR0.00 Mil as of . 20.

Farabi Pharmaceutical's Total Operating Expense for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical Total Operating Expense Related Terms

Farabi Pharmaceutical Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Total Operating Expense Chart

Farabi Pharmaceutical Annual Data
Trend
Total Operating Expense

Farabi Pharmaceutical Quarterly Data
Total Operating Expense

Farabi Pharmaceutical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was IRR0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Total Operating Expense of IRR0.00 Mil as of . 20. Total operating expense is the primary recurring expense associated with central operations. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Total Operating Expense too high?
Farabi Pharmaceutical's current Total Operating Expense is IRR0.00 Mil.
How does Farabi Pharmaceutical's Total Operating Expense compare to IMNPQ and INNV?
Farabi Pharmaceutical's Total Operating Expense of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Total Operating Expense is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Total Operating Expense of IRR0.00 Mil. The current Total Operating Expense is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Total Operating Expense is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.